Zhu Jingjin, Liu Mei, Li Xiru
School of Medicine, Nankai University, Tianjin, China.
Department of Pathology, Chinese People's Liberation Army General Hospital, Beijing, China.
Gland Surg. 2022 Apr;11(4):751-766. doi: 10.21037/gs-22-11.
Pathology is the gold standard criteria for breast cancer diagnosis and has important guiding value in formulating the clinical treatment plan and predicting the prognosis. However, traditional microscopic examinations of tissue sections are time consuming and labor intensive, with unavoidable subjective variations. Deep learning (DL) can evaluate and extract the most important information from images with less need for human instruction, providing a promising approach to assist in the pathological diagnosis of breast cancer. To provide an informative and up-to-date summary on the topic of DL-based diagnostic systems for breast cancer pathology image analysis and discuss the advantages and challenges to the routine clinical application of digital pathology.
A PubMed search with keywords ("breast neoplasm" or "breast cancer") and ("pathology" or "histopathology") and ("artificial intelligence" or "deep learning") was conducted. Relevant publications in English published from January 2000 to October 2021 were screened manually for their title, abstract, and even full text to determine their true relevance. References from the searched articles and other supplementary articles were also studied.
DL-based computerized image analysis has obtained impressive achievements in breast cancer pathology diagnosis, classification, grading, staging, and prognostic prediction, providing powerful methods for faster, more reproducible, and more precise diagnoses. However, all artificial intelligence (AI)-assisted pathology diagnostic models are still in the experimental stage. Improving their economic efficiency and clinical adaptability are still required to be developed as the focus of further researches.
Having searched PubMed and other databases and summarized the application of DL-based AI models in breast cancer pathology, we conclude that DL is undoubtedly a promising tool for assisting pathologists in routines, but further studies are needed to realize the digitization and automation of clinical pathology.
病理学是乳腺癌诊断的金标准,对制定临床治疗方案及预测预后具有重要指导价值。然而,传统的组织切片显微镜检查耗时且费力,存在不可避免的主观差异。深度学习(DL)能够在较少人工干预的情况下评估并提取图像中最重要的信息,为辅助乳腺癌病理诊断提供了一种有前景的方法。旨在提供关于基于深度学习的乳腺癌病理图像分析诊断系统这一主题的信息丰富且最新的综述,并讨论数字病理学在常规临床应用中的优势与挑战。
在PubMed数据库中以关键词(“乳腺肿瘤”或“乳腺癌”)、(“病理学”或“组织病理学”)以及(“人工智能”或“深度学习”)进行检索。手动筛选2000年1月至2021年10月发表的英文相关出版物,查看其标题、摘要甚至全文,以确定其真正相关性。还研究了检索文章及其他补充文章的参考文献。
基于深度学习的计算机图像分析在乳腺癌病理诊断、分类、分级、分期及预后预测方面取得了令人瞩目的成就,为更快、更具可重复性和更精确的诊断提供了有力方法。然而,所有人工智能(AI)辅助的病理诊断模型仍处于实验阶段。提高其经济效率和临床适应性仍是进一步研究需关注的重点。
通过检索PubMed及其他数据库并总结基于深度学习的人工智能模型在乳腺癌病理学中的应用,我们得出结论,深度学习无疑是辅助病理学家日常工作的一种有前景的工具,但要实现临床病理学的数字化和自动化还需要进一步研究。